Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1391 to 1400 of 5733 Results
March 30, 2021
Takeda secures global rights from Ovid Therapeutics to develop and commercialize Soticlestat
$856 Million
March 29, 2021
Lazard advised AD Education's founder and other shareholders (Cathay Capital and Bpifrance) on its disposal to Ardian
Undisclosed
March 29, 2021
Lazard advised AD Educations founder and other shareholders (Cathay Capital and Bpifrance) on its disposal to Ardian
Undisclosed
March 29, 2021
Sumitovant Biopharma to acquire Urovant Sciences
$681 Million
March 26, 2021
HLD Europe to acquire majority stake in Microwave Vision for EUR 26 a share
$197 Million
March 24, 2021
Charterhouse Capital Partners announces partial sale of Funecap, continues to support next phase of growth
Undisclosed
March 24, 2021
Charterhouse Capital Partners announces partial sale of Funecap, continues to support next phase of growth
Undisclosed
March 24, 2021
AccorInvest completes its financial restructuring
$6.5 Billion
March 23, 2021
The Hellenic Republic issues a €2.5bn 1.875% 30-year bond due 2052, out of demand in excess of €25bn
$2.9 Billion
March 22, 2021